Analyst Activity – Wells Fargo & Co Reiterates Outperform on NYSE:ZYME – Zymeworks (NYSE:ZYME)

ME Staff
-
0

Analyst Ratings For NYSE:ZYME – Zymeworks (NYSE:ZYME)

Today, Wells Fargo & Co reiterated its Outperform rating on NYSE:ZYME – Zymeworks (NYSE:ZYME) with a price target of $20.00 ➝ $37.00.

Some recent analyst ratings include

  • 6/4/2018-Wells Fargo & Co Reiterated Rating of Outperform.
  • 5/14/2018-LADENBURG THALM/SH SH initiated coverage with a Buy rating.
  • 5/11/2018-Barclays Upgrade from a “Underweight ➝ Equal Weight” rating to a “” rating.
  • 9/30/2017-Cormark Reiterated Rating of Buy.
  • 5/23/2017-Citigroup initiated coverage with a Buy ➝ Buy rating.


    Recent Trading Activity for NYSE:ZYME – Zymeworks (NYSE:ZYME)
    Shares of NYSE:ZYME – Zymeworks closed the previous trading session at 18.55 down -3.31 15.14% with 20.010000228881836 shares trading hands.